About IAME
Our laboratory, entitled IAME for “Infection, Antimicrobials, Modelling, Evolution”, is an alliance from basic to clinical and population-based research towards medical progress in the fight against infectious diseases.
Created in 2014, IAME is affiliated with the French Institute for Medical Research (INSERM), the University Paris Cité (UPCité) and the University Sorbonne Paris Nord (USPN).
It is located at the UPCité Bichat Medical School campus in Northern Paris and connected to several hospitals from the Assistance Publique – Hôpitaux de Paris (AP-HP).
IAME provides a unique opportunity to mix basic scientists from various disciplines (mathematicians, statisticians, economists, bacteriologists, virologists) and clinicians involved in infectious disease research.
Key figures
IAME day, 23 May 2024
Focus on...
Papers of the month
Epidemiology and management of HIV-2
The Lancet HIV
Deciphering acquired resistance to amikacin in Mycobacterium abscessus clinical isolates selected from patients with pulmonary disease (MAB-PD) treated with aminoglycoside: a 2012-2025 retrospective cohort study
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
Viral Dynamics of the Respiratory Syncytial Virus During Experimental Human Challenge: Implication for Transmission and Protection
The Journal of Infectious Diseases
News
Appel Émergence Recherche « Début de carrière » 2026 : 2 projets IAME financés !
Nathalie Bechon (équipe EVRest) : Étude des interactions entre les bactéries intestinales Bacteroides et leurs bactériophages : défenses moléculaires et déterminants environnementaux
Delphine Planas (équipe PreViST) : Infection par le métapneumovirus humain : déterminants de l’entrée virale, tropisme respiratoire et dynamique de l’infection en cellules vivantes
Léa Lenglart lauréate du prix L'Oréal-UNESCO Pour les Femmes et la Science France 2026
Léa Lenglart (équipe EPIC) - Comparer les stratégies européennes pour prévenir la bronchiolite du nourrisson
Parution du livre « Epidémia » de Xavier Lescure
Xavier Lescure, médecin infectiologue dans IAME (équipe PreViST), aborde les futures épidémies potentielles, exacerbées par le dérèglement climatique, la déforestation et la mondialisation. Il souligne que le Covid-19 n’était qu’un avertissement et que la société doit être prête pour les pandémies à venir.
Research teams
Etienne Ruppé
Imane El Meouche
Team EVRest “Ecology, Evolution and Therapeutic of Virulence and Resistance in Bacteria”, achieves a better understanding of the ecological, evolutionary and molecular parameters allowing the adaptation of natural isolates of the Escherichia coli species to their various lifestyles, especially those involved in the emergence of virulence and antimicrobial resistance and develops new original therapeutic approaches to fight this pathogen.
Jérémie Guedj
Team MOCLID “Statistical Modelling and Clinical Investigation in Infectious Diseases”, develops statistical methods for analysis of longitudinal data obtained in clinical trials and performs clinical investigation in the treatment of infectious diseases.
Charlotte Charpentier
Jade Ghosn
Team PreViST “Pathogenesis, Treatment and Prevention strategies of Viral Infections and Sexually Transmitted Infections” is evaluating interventions designed for infectious diseases prevention, control, and care. PreViST is focusing on chronic viral infections, emerging viral infections, and bacterial and viral sexually transmitted infections. The team includes five research axes.
Naïm Ouldali
Romain Basmaci
Team EPIC “REducing the burden of Pneumococcal disease In Children”, created in April 2024 as an ATIP/AVENIR INSERM team, is dedicated to epidemiological and clinical research on severe community-acquired pediatric infectious diseases. Specifically, this team addresses the issue of modelling the adaptive evolution of Streptococcus pneumoniae following human interventions and predicting the potential impact of innovative public health interventions aimed at reducing the burden of respiratory infections in children.